Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

NCT05953545 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Stopped Study closure based on decision of the PI

Conditions

Chronic Hepatitis Delta

Interventions

DRUG: Peginterferon Lambda

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)